Private Advisor Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,320
| Closed | -$226K | – | 2026 |
|
|
2023
Q1 | $226K | Buy |
+2,320
| New | +$226K | ﹤0.01% | 1724 |
|
|
2022
Q4 | – | Sell |
-3,021
| Closed | -$256K | – | 1696 |
|
|
2022
Q3 | $256K | Buy |
3,021
+180
| +6% | +$15.3K | ﹤0.01% | 1556 |
|
|
2022
Q2 | $235K | Buy |
+2,841
| New | +$235K | ﹤0.01% | 1761 |
|
|
2022
Q1 | – | Sell |
-5,078
| Closed | -$449K | – | 2098 |
|
|
2021
Q4 | $449K | Buy |
5,078
+893
| +21% | +$79K | ﹤0.01% | 1495 |
|
|
2021
Q3 | $323K | Buy |
+4,185
| New | +$323K | ﹤0.01% | 1686 |
|
|
2021
Q1 | – | Sell |
-3,520
| Closed | -$309K | – | 1881 |
|
|
2020
Q4 | $309K | Sell |
3,520
-764
| -18% | -$67.1K | ﹤0.01% | 1440 |
|
|
2020
Q3 | $326K | Buy |
4,284
+1,087
| +34% | +$82.7K | ﹤0.01% | 1222 |
|
|
2020
Q2 | $394K | Buy |
3,197
+104
| +3% | +$12.8K | 0.01% | 1104 |
|
|
2020
Q1 | $261K | Buy |
3,093
+83
| +3% | +$7K | ﹤0.01% | 1134 |
|
|
2019
Q4 | $254K | Sell |
3,010
-166
| -5% | -$14K | ﹤0.01% | 1352 |
|
|
2019
Q3 | $214K | Sell |
3,176
-1,222
| -28% | -$82.3K | ﹤0.01% | 1455 |
|
|
2019
Q2 | $377K | Sell |
4,398
-853
| -16% | -$73.1K | 0.01% | 1175 |
|
|
2019
Q1 | $467K | Buy |
5,251
+599
| +13% | +$53.3K | 0.01% | 1001 |
|
|
2018
Q4 | $396K | Sell |
4,652
-502
| -10% | -$42.7K | 0.01% | 922 |
|
|
2018
Q3 | $500K | Sell |
5,154
-6,811
| -57% | -$661K | 0.01% | 994 |
|
|
2018
Q2 | $1.13M | Buy |
+11,965
| New | +$1.13M | 0.02% | 442 |
|
|
2017
Q4 | – | Sell |
-4,111
| Closed | -$390K | – | 1200 |
|
|
2017
Q3 | $390K | Sell |
4,111
-1,098
| -21% | -$104K | 0.01% | 1005 |
|
|
2017
Q2 | $468K | Sell |
5,209
-718
| -12% | -$64.5K | 0.01% | 867 |
|
|
2017
Q1 | $511K | Buy |
5,927
+2,430
| +69% | +$210K | 0.01% | 820 |
|
|
2016
Q4 | $300K | Buy |
3,497
+877
| +33% | +$75.2K | 0.01% | 949 |
|
|
2016
Q3 | $249K | Buy |
2,620
+145
| +6% | +$13.8K | 0.01% | 912 |
|
|
2016
Q2 | $200K | Buy |
+2,475
| New | +$200K | 0.01% | 993 |
|